Adalimumab in the treatment of pediatric patients with chronic noninfectious anterior uveitis

被引：3

作者：

Gunzinger, Jeanne ^{[1
]}

Moore, Phoebe ^{[1
]}

Athimalaipet, Ramanan ^{[2
,3
,4
]}

Dick, Andrew ^{[5
,6
,7
]}

机构：

[1] Bristol Eye Hosp, Dept Uveitis, Bristol, Avon, England

[2] Bristol Royal Hosp Children, Upper Maudlin St, Bristol BS2 8BJ, Avon, England

[3] Univ Bristol, Univ Hosp Bristol NHs Fdn Trust, Bristol, Avon, England

[4] Univ Bristol, Translat Hlth Sci, Bristol, Avon, England

[5] Bristol Eye Hosp, Inst Ophthalmol, Bristol, Avon, England

[6] Moorfields Eye Hosp, Biomed Res Ctr, Natl Inst Hlth Res, London, England

[7] UCL, London, England

来源：

EXPERT REVIEW OF OPHTHALMOLOGY | 2021年 / 16卷 / 04期

关键词：

Adalimumab; noninfectious pediatric uveitis; pediatric uveitis; anti-drug antibodies; uveitis treatment; adalimumab monitoring; JUVENILE IDIOPATHIC ARTHRITIS; LONG-TERM TREATMENT; RHEUMATOID-ARTHRITIS; TNF-ALPHA; DISEASE-ACTIVITY; BIOLOGICAL THERAPIES; REFRACTORY UVEITIS; EFFICACY; CHILDREN; TOCILIZUMAB;

D O I：

10.1080/17469899.2021.1935240

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Introduction: Adalimumab is established as an effective treatment for pediatric noninfectious uveitis refractory to methotrexate. However current use of the medication is empiric, according to fixed-dosing regimens and a significant proportion of patients will be nonresponsive or suboptimally responsive to adalimumab. Areas covered: There remains considerable scope to improve outcomes through tailoring treatment according to individual patient responsiveness. Monitoring of anti-drug antibodies and serum drug trough levels may assist in predicting which patients are likely to have a poor response to adalimumab and enable tailoring of regimens to individual patients. Expert opinion: We propose use of these biomarkers to individualize therapy in suboptimally responding patients, and present an algorithm of treatment escalation for pediatric noninfectious uveitis.

引用

页码：231 / 241

页数：11

共 99 条

[1] Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST-Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial [J].

Acharya, Nisha R. ;

Ebert, Caleb D. ;

Kelly, Nicole K. ;

Porco, Travis C. ;

Ramanan, Athimalaipet V. ;

Arnold, Benjamin F. .

TRIALS, 2020, 21 (01)

[2] Relapse of Juvenile Idiopathic Arthritis-Associated Uveitis after Discontinuation of Immunomodulatory Therapy [J].

Acharya, Nisha R. ;

Patel, Sarju ;

Homayounfar, Gelareh ;

Enanoria, Wayne T. A. ;

Shakoor, Akbar ;

Chakrabarti, Anindita ;

Goldstein, Debra A. .

OCULAR IMMUNOLOGY AND INFLAMMATION, 2019, 27 (04) :686-692

[3] Tocilizumab treatment for recalcitrant uveitic macular edema [J].

Adan, Alfredo ;

Llorenc, Victor ;

Mesquida, Marina ;

Pelegrin, Laura .

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 251 (09) :2249-2250

[4] Patterns of uveitis in children according to age: comparison of visual outcomes and complications in a tertiary center [J].

Al-Haddad, Christiane ;

BouGhannam, Alaa ;

Fattah, Maamoun Abdul ;

Tamim, Hani ;

El Moussawi, Zeinab ;

Hamam, Rola N. .

BMC OPHTHALMOLOGY, 2019, 19 (1)

[5] 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis [J].

Angeles-Han, Sheila T. ;

Ringold, Sarah ;

Beukelman, Timothy ;

Lovell, Daniel ;

Cuello, Carlos A. ;

Becker, Mara L. ;

Colbert, Robert A. ;

Feldman, Brian M. ;

Holland, Gary N. ;

Ferguson, Polly J. ;

Gewanter, Harry ;

Guzman, Jaime ;

Horonjeff, Jennifer ;

Nigrovic, Peter A. ;

Ombrello, Michael J. ;

Passo, Murray H. ;

Stoll, Matthew L. ;

Rabinovich, C. Egla ;

Sen, H. Nida ;

Schneider, Rayfel ;

Halyabar, Olha ;

Hays, Kimberly ;

Shah, Amit Aakash ;

Sullivan, Nancy ;

Szymanski, Ann Marie ;

Turgunbaev, Marat ;

Turner, Amy ;

Reston, James .

ARTHRITIS & RHEUMATOLOGY, 2019, 71 (06) :864-877

[6] Predictors of Flare Following Etanercept Withdrawal in Patients with Rheumatoid Factor-negative Juvenile Idiopathic Arthritis Who Reached Remission while Taking Medication [J].

Aquilani, Angela ;

Marafon, Denise Pires ;

Marasco, Emiliano ;

Nicolai, Rebecca ;

Messia, Virginia ;

Perfetti, Francesca ;

Magni-Manzoni, Silvia ;

De Benedetti, Fabrizio .

JOURNAL OF RHEUMATOLOGY, 2018, 45 (07) :956-961

[7] Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children With Crohn's Disease Compared With Reactive Monitoring [J].

Assa, Amit ;

Matar, Manar ;

Turner, Dan ;

Broide, Efrat ;

Weiss, Batia ;

Ledder, Oren ;

Guz-Mark, Anat ;

Rinawi, Firas ;

Cohen, Shlomi ;

Topf-Olivestone, Chani ;

Shaoul, Ron ;

Yerushalmi, Baruch ;

Shamir, Raanan .

GASTROENTEROLOGY, 2019, 157 (04) :985-+

[8] Pathogenesis of juvenile idiopathic arthritis associated uveitis: the known and unknown [J].

Ayuso, Viera Kalinina ;

Makhotkina, Nathalia ;

van Tent-Hoeve, Maretta ;

de Groot-Mijnes, Jolanda D. F. ;

Wulffraat, Nico M. ;

Rothova, Aniki ;

de Boer, Joke H. .

SURVEY OF OPHTHALMOLOGY, 2014, 59 (05) :517-531

[9] Relapse Rate of Uveitis Post-Methotrexate Treatment in Juvenile Idiopathic Arthritis [J].

Ayuso, Viera Kalinina ;

van de Winkel, Evelyne Leonce ;

Rothova, Aniki ;

de Boer, Joke Helena .

AMERICAN JOURNAL OF OPHTHALMOLOGY, 2011, 151 (02) :217-222

[10] Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) Study [J].

Baddley, John W. ;

Winthrop, Kevin L. ;

Chen, Lang ;

Liu, Liyan ;

Grijalva, Carlos G. ;

Delzell, Elizabeth ;

Beukelman, Timothy ;

Patkar, Nivedita M. ;

Xie, Fenglong ;

Saag, Kenneth G. ;

Herrinton, Lisa J. ;

Solomon, Daniel H. ;

Lewis, James D. ;

Curtis, Jeffrey R. .

ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (11) :1942-1948

← 1 2 3 4 5 6 7 8 9 10 →